Jul 13, 2026 02:07PM
Jun 29, 2026 09:29AM
Jun 26, 2026 08:15AM
Jun 26, 2026 06:58AM
Jun 22, 2026 11:24AM
Jun 8, 2026 01:05PM
Jun 8, 2026 07:00AM Kymera presents preclinical lupus data for oral IRF5 degrader KT-579
May 15, 2026 07:00AM
May 6, 2026 05:09AM
May 5, 2026 07:01AM
Apr 30, 2026 12:01PM
Apr 30, 2026 07:05AM
Apr 13, 2026 05:52AM
Apr 10, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Kymera Therapeutics (KYMR)
Apr 9, 2026 07:03AM
Mar 30, 2026 04:21AM
Mar 18, 2026 09:21AM
Mar 2, 2026 07:21AM
Feb 26, 2026 03:25PM
Feb 26, 2026 11:56AM
Feb 26, 2026 11:56AM Kymera Therapeutics (KYMR) PT Raised to $108 at RBC Capital
Feb 26, 2026 10:53AM
Feb 26, 2026 07:14AM
Feb 25, 2026 04:10PM
Jan 29, 2026 07:02AM
Jan 13, 2026 07:01AM
Jan 6, 2026 05:35AM
Dec 16, 2025 05:15AM Kymera Therapeutics (KYMR) PT Raised to $103 at RBC Capital
Dec 11, 2025 07:33AM
Dec 11, 2025 04:43AM
Dec 10, 2025 08:25AM
Dec 9, 2025 02:27PM
Dec 9, 2025 08:46AM
Dec 9, 2025 06:10AM
Dec 9, 2025 05:33AM Kymera Therapeutics (KYMR) PT Raised to $116 at Wells Fargo
Dec 8, 2025 04:07PM
Dec 8, 2025 04:01PM
Dec 8, 2025 04:00PM
Dec 8, 2025 09:56AM
Dec 8, 2025 06:59AM
Nov 26, 2025 08:55AM
Nov 25, 2025 07:01AM Kymera Therapeutics starts phase 2b atopic dermatitis trial
Nov 16, 2025 03:00PM
Nov 14, 2025 08:08AM
Nov 5, 2025 06:17AM
Nov 4, 2025 01:19PM
Nov 4, 2025 07:04AM
Nov 3, 2025 02:33AM
Oct 27, 2025 07:00AM Kymera presents preclinical data for oral IRF5 degrader KT-579
Oct 24, 2025 05:27AM

428,611 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All